Register entry

Tetraphase Pharmaceuticals, Inc.

Data as of · How to read this entry

Registered sites
0
Active NDC listings
2
Live patents
8
Exclusivities
1
Countries
0
Catalogue

Drug listings by form and route

2

2 active NDC listings: 2 human prescription drug. By marketing category: NDA 2.

Dosage formNDCs
injection, powder, lyophilized, for solution2
RouteNDCs
intravenous2
Labeller name on the listingNDCs
tetraphase pharmaceuticals, inc.2
Exclusivity

Patents and exclusivities

8
PatentProductCoversExpiry
8796245XERAVAeravacycline dihydrochlorideuseAug 2029
8906887XERAVAeravacycline dihydrochlorideproductAug 2032
10961190XERAVAeravacycline dihydrochloridesubstanceOct 2037
11578044XERAVAeravacycline dihydrochloridesubstanceOct 2037
ProductExclusivityUntil
XERAVAERAVACYCLINE DIHYDROCHLORIDEGAIN Qualified infectious disease product (GAIN)Aug 2028
Catalogue

Marketed products

2
BrandGeneric nameForm / routeNDC
Xeravaeravacyclineinjection, powder, lyophilized, for solution, intravenous71773-050NDA
Xeravaeravacyclineinjection, powder, lyophilized, for solution, intravenous71773-100NDA
Enquiry

Common questions

Is Tetraphase Pharmaceuticals, Inc. FDA approved?
Tetraphase Pharmaceuticals, Inc. holds no registered establishment of its own; 2 drug products are listed under its name in the National Drug Code Directory, made at sites registered to other firms.
What drugs does Tetraphase Pharmaceuticals, Inc. make?
2 products are listed under Tetraphase Pharmaceuticals, Inc. in the openFDA NDC Directory, most often as injection, powder, lyophilized, for solution. The full breakdown by dosage form and route is above. A listing count is not a sales figure.

Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.